Hepatitis B News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

New vaccine protects adults against Hepatitis B - WKBT - News8000.com - WKBT



WRCB-TV
 
New vaccine protects adults against Hepatitis B - WKBT 
News8000.com - WKBT
LA CROSSE, Wis. (WKBT) - A new Hepatitis B vaccine -- the first in 25 years -- comes at a time when cases of the virus are rising, a trend some link to the heroin and drug epidemic. For the past two decades, there has been a vaccination against the ...
US panel recommends new adult vaccine against Hepatitis B ... WRCB-TV
Two-Dose Hep B Vaccine Approved by CDC - Precision Vaccinations PrecisionVaccinations (press release)
The rising concern of Hepatitis B BSI bureau (press release)
Gephardt Daily 
all 17 news articles » 


Global Hepatitis B Virus Treatment (Therapeutics, Vaccine) Market 2017-2022 - Market Driven by Increase in ... - PR Newswire (press release)



PR Newswire (press release)
 
Global Hepatitis B Virus Treatment (Therapeutics, Vaccine) Market 2017-2022 - Market Driven by Increase in ... 
PR Newswire (press release)
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection ...
Global Hepatitis B Virus Treatment (Therapeutics, Vaccine) Market ... GlobeNewswire (press release)

all 3 news articles » 


Orphan Drug Designation Granted to Pediatric Hepatitis B Therapy - Rare Disease Report



CNA Finance
 
Orphan Drug Designation Granted to Pediatric Hepatitis B Therapy 
Rare Disease Report
This morning, ContraVir Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to tenofovir exalidex (TXL), an investigational drug candidate for the potential treatment of chronic hepatitis ...
ContraVir Pharmaceuticals Announces TXL? Has Been Granted Orphan Drug Designation for the Treatment of HBV in ... GlobeNewswire (press release)
ContraVir Pharma (CTRV) Announces TXL Granted Orphan Drug Designation for Treatment of HBV in Pediatric ... StreetInsider.com

all 11 news articles » 


US panel recommends new adult vaccine against hepatitis B | The ... - The San Luis Obispo Tribune



The San Luis Obispo Tribune
 
US panel recommends new adult vaccine against hepatitis B | The ... 
The San Luis Obispo Tribune
Federal advisory panel recommends new vaccine against hepatitis B for adults.
Dynavax's HEPLISAV-B? [Hepatitis B Vaccine (Recombinant ... PharmiWeb.com (press release)
ACIP Backs HEPLISAV-B, GMED Hits New High, GWPH's Focal ... Nasdaq

all 3 news articles » 


Organ-on-a-Chip Technology Used to Spot New Hepatitis B Drug Targets - Labiotech.eu (blog)



Labiotech.eu (blog)
 
Organ-on-a-Chip Technology Used to Spot New Hepatitis B Drug Targets 
Labiotech.eu (blog)
Scientists in London are the first in the world to test how pathogens like the hepatitis B virus interact with artificial human organs. Researchers at Imperial College London have used artificial human organs, or organs-on-chips, to replicate the make ...

 


Hepatitis B Infects Organ-on-a-Chip Platform - Genetic Engineering & Biotechnology News



Genetic Engineering & Biotechnology News
 
Hepatitis B Infects Organ-on-a-Chip Platform 
Genetic Engineering & Biotechnology News
For the first time, a real pathogen has instigated a real disease process in an artificial organ, and scientists are really, really pleased. As far as scientists are concerned, the whole point of an artificial organ?in this case, a liver-on-a-chip ...
Organ-on-chip technology enters next stage as experts test hepatitis B virus Science Daily
Organ-on-chip technology revels hepatitis B virus interactions with ... Clinical Innovation + Technology
Organ-on-chip technology enters the next stage as specialists test ... Tech Explorist (press release)
MedicalResearch.com (blog) 
all 7 news articles » 


New Jersey Health Foundation grants $50k to hepatitis B, E research - Healio



Infectious Disease Advisor
 
New Jersey Health Foundation grants $50k to hepatitis B, E research 
Healio
The New Jersey Health Foundation awarded a $50000 Innovation Grant to Alexander Ploss, PhD, assistant professor of molecular biology at Princeton University, for hepatitis B and hepatitis E treatment research, according to a press release. ?Fortunately ...
Rate of Hepatitis B Reactivation During DAA Therapy for Hepatitis C ... Infectious Disease Advisor

all 2 news articles » 


Xconomy: Arrowhead Plans Return to Clinic With New Study of Hep ... - Xconomy



Xconomy
 
Xconomy: Arrowhead Plans Return to Clinic With New Study of Hep ... 
Xconomy
On Thursday, Pasadena, CA-based Arrowhead?which houses its research and development operations in Madison, WI?said regulators cleared the company to initiate a clinical study of a drug it's developing to treat chronic hepatitis B virus. Arrowhead ...

and more » 


'Virus-cracking' molecules advance fight against hepatitis B ... - Science Daily



Science Daily
 
'Virus-cracking' molecules advance fight against hepatitis B ... 
Science Daily
Researchers have found that certain molecules -- currently under clinical trial -- are able to 'crack' the protective shell of the hepatitis B virus, suggesting it may be possible to attack the virus after its already taken hold in the body. There is ...

and more »